{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:30:44Z","timestamp":1776843044143,"version":"3.51.2"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272200800008C"],"award-info":[{"award-number":["HHSN272200800008C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201300020I"],"award-info":[{"award-number":["HHSN272201300020I"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,10,20]]},"abstract":"<jats:p>Neurocysticercosis and trichuriasis are difficult-to-treat parasitic infections that affect more than 1.5 billion people worldwide. Oxfendazole, a potent broad-spectrum benzimidazole anthelmintic approved for use in veterinary medicine, has shown substantial antiparasitic activity against neurocysticercosis and intestinal helminths in preclinical studies. As part of a program to transition oxfendazole from veterinary medicine to human use, phase I multiple ascending dose and food effect studies were conducted.<\/jats:p>","DOI":"10.1128\/aac.01018-20","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T12:39:11Z","timestamp":1597235951000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study"],"prefix":"10.1128","volume":"64","author":[{"given":"Thanh","family":"Bach","sequence":"first","affiliation":[{"name":"Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Galbiati","sequence":"additional","affiliation":[{"name":"The Emmes Company, Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie K.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"The Emmes Company, Rockville, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Deye","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie Y. H.","family":"Nomicos","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen E.","family":"Codd","sequence":"additional","affiliation":[{"name":"Codd Consulting, LLC, Blue Bell, Pennsylvania, USA"},{"name":"Oxfendazole Development Group, Blue Bell, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector H.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Oxfendazole Development Group, Blue Bell, Pennsylvania, USA"},{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[{"name":"Oxfendazole Development Group, Blue Bell, Pennsylvania, USA"},{"name":"Tropical Projects, Hitchin, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Gilman","sequence":"additional","affiliation":[{"name":"Oxfendazole Development Group, Blue Bell, Pennsylvania, USA"},{"name":"Johns Hopkins School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando E.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Oxfendazole Development Group, Blue Bell, Pennsylvania, USA"},{"name":"Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru"},{"name":"School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Winokur","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-7663","authenticated-orcid":false,"given":"Guohua","family":"An","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"WHO. 2017. Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. WHO Geneva Switzerland."},{"key":"e_1_3_2_3_2","unstructured":"WHO. 2012. Eliminating soil-transmitted helminthiases as a public health problem in children: progress report 2001\u20132010 and strategic plan 2011\u20132020. WHO Geneva Switzerland."},{"key":"e_1_3_2_4_2","unstructured":"WHO. 2018. Soil transmitted helminth infections. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections. Accessed 30 December 2019."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1937"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031294"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.141324"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.5.1421"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001457"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2017.03.005"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-7-255"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002119"},{"key":"e_1_3_2_13_2","first-page":"297","article-title":"Dose titration of oxfendazole against common nematodes of swine","volume":"40","author":"Corwin RM","year":"1979","unstructured":"Corwin RM, Kennedy JA, Pratt SE. 1979. Dose titration of oxfendazole against common nematodes of swine. Am J Vet Res 40:297\u2013298.","journal-title":"Am J Vet Res"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2013.01.003"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2013.06.010"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1996.54.391"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.141.16.420"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.59.832"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1995.53.571"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1555241"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2007.06.028"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1995.tb00578.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2012.07.023"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(96)90010-7"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02255-18"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00540964"},{"key":"e_1_3_2_27_2","unstructured":"Janssen. 2017. Mebendazole label on Janssen. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/208398s000lbl.pdf. Accessed 26 January 2019."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.16.070196.002123"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp3006566"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2014.03.003"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004971"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2017.11.002"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000410"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.5"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.04.069"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297133"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1091581815569582"},{"key":"e_1_3_2_38_2","unstructured":"Fuchs R. Oxfendazole. http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v29je05.htm. Accessed 30 December 2019."},{"key":"e_1_3_2_39_2","unstructured":"FAO. 1998. Residues of some veterinary drugs in foods and animals: 41\u20134-oxfendazole. http:\/\/www.fao.org\/fileadmin\/user_upload\/vetdrug\/docs\/41-4-oxfendazole.pdf."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.03.048"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01018-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01018-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:34:09Z","timestamp":1645479249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01018-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10,20]]}},"alternative-id":["10.1128\/AAC.01018-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01018-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"2020-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01018-20"}}